---
title: "Top 10 US Stock Gainers (11.19)"
description: "Semrush(SEMR) rose 73.96%, with a trading turnover 512.7 Million USD, and a year-to-date fell 1%. Nuvation Bio(NUVB) rose 48.96%, with a trading turnover 399.5 Million USD, and a year-to-date rose 168"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/266623764.md"
published_at: "2025-11-19T22:01:01.000Z"
---

# Top 10 US Stock Gainers (11.19)

> Semrush(SEMR) rose 73.96%, with a trading turnover 512.7 Million USD, and a year-to-date fell 1%. Nuvation Bio(NUVB) rose 48.96%, with a trading turnover 399.5 Million USD, and a year-to-date rose 168.8%. Sigma Lithium(SGML) rose 33.33%, with a trading turnover 400.6 Million USD, and a year-to-date fell 7.7%.

NASDAQ Composite Index has rose 0.59%, with a year-to-date rose 16.8%; S&P 500 has rose 0.38%, with a year-to-date rose 12.9%; Dow Jones Industrial Average has rose 0.1%, with a year-to-date rose 8.4%.

Semrush(SEMR) rose 73.96%, with a trading turnover 512.7 Million USD, and a year-to-date fell 1%.

Nuvation Bio(NUVB) rose 48.96%, with a trading turnover 399.5 Million USD, and a year-to-date rose 168.8%.

Sigma Lithium(SGML) rose 33.33%, with a trading turnover 400.6 Million USD, and a year-to-date fell 7.7%.

### Related Stocks

- [SEMR.US - Semrush](https://longbridge.com/en/quote/SEMR.US.md)
- [NUVB.US - Nuvation Bio](https://longbridge.com/en/quote/NUVB.US.md)
- [SGML.US - Sigma Lithium](https://longbridge.com/en/quote/SGML.US.md)
- [EXAS.US - Exact Sciences](https://longbridge.com/en/quote/EXAS.US.md)
- [LZB.US - LA-Z Boy](https://longbridge.com/en/quote/LZB.US.md)
- [AMTM.US - Amentum](https://longbridge.com/en/quote/AMTM.US.md)
- [PVLA.US - Palvella Therapeutics](https://longbridge.com/en/quote/PVLA.US.md)
- [PACS.US - PACS](https://longbridge.com/en/quote/PACS.US.md)
- [TMDX.US - TransMedics](https://longbridge.com/en/quote/TMDX.US.md)
- [BRBR.US - Bellring Brands](https://longbridge.com/en/quote/BRBR.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Key facts: Exact Sciences to merge with Abbott by Q2 2026; 2025 revenue up 18% | Exact Sciences Corp. is merging with Abbott Laboratories, set to finalize in Q2 2026, pending approvals. The company als | [Link](https://longbridge.com/en/news/275986686.md) |
| 13 Analysts Have This To Say About Amentum Holdings | 13 analysts have provided varied opinions on Amentum Holdings (NYSE:AMTM), with ratings ranging from bullish to bearish. | [Link](https://longbridge.com/en/news/275600587.md) |
| 18:51 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sigma Lithium Corporation - SGML | Pomerantz Law Firm is investigating claims on behalf of investors of Sigma Lithium Corporation (NASDAQ: SGML) regarding  | [Link](https://longbridge.com/en/news/275824572.md) |
| Amentum Holdings: Q1 Earnings Insights | Amentum Holdings (NYSE:AMTM) reported its Q1 earnings on February 9, 2026, revealing an EPS of $0.54, beating estimates  | [Link](https://longbridge.com/en/news/275365839.md) |
| TransMedics erhält vollständige FDA-IDE-Zulassung für OCS Heart ENHANCE Trial | TransMedics Group Inc. has received full and unrestricted approval from the U.S. Food and Drug Administration (FDA) for  | [Link](https://longbridge.com/en/news/275321278.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.